[Cerebral cryptococcosis associated with etanercept].
Chávez-López
Mario
M
Márquez-Díaz
Francisco
F
Aguayo-Leytte
Gerónimo
G
D000369:Aged, 80 and over; D001327:Autoimmune Diseases / Q000188:drug therapy; D004198:Disease Susceptibility; D000068800:Etanercept; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016919:Meningitis, Cryptococcal / Q000209:etiology*; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept